What is Nurix Therapeutics, Inc.'s AOCI?

Nurix Therapeutics, Inc. (NRIX) reported AOCI of $56K in Q4 2025.

How has Nurix Therapeutics, Inc.'s AOCI changed year-over-year?

Nurix Therapeutics, Inc.'s AOCI decreased by 75.2% year-over-year, from $226K to $56K.

What is the long-term trend for Nurix Therapeutics, Inc.'s AOCI?

Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s AOCI has grown at a 3.8% compound annual growth rate (CAGR), from $87K to $105K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Nurix Therapeutics, Inc. NRIX AOCI

AOCI at other companies

Kymera TherapeuticsKYMR

-$4.19M-7,131%

Monte Rosa Therapeutics, Inc.GLUE

-$4.75M-42.6%

Stoke Therapeutics, Inc.STOK

-$115K-10.6%

Viridian Therapeutics, Inc.VRDN

-$558K-328%

Nuvation BioNUVB

-$1.68M-408%

Ultragenyx PharmaceuticalRARE

$0+100%

Other financials

Income statement

See full

Revenue$6.3M-66.1%

Operating income-$92.5M-47.1%

Net income-$87.2M-54.7%

EPS (diluted)-$0.79-17.9%

Balance sheet

See full

Cash & equivalents$72.2M-6.1%

Total debt$58.7M+120%

Total equity$480.9M0.0%

Total assets$636.1M+3.4%

Cash flow

See full

Operating cash flow-$71.9M-17.7%

CapEx$1.0M-70.0%

Free cash flow-$73.0M-13.0%

Valuation

See full

Market cap$1.95B+40.1%

Enterprise value$1.94B+45.1%

P/S27.2×+2.5×

Profitability

See full

Operating margin-439.3%+35.3pp

Net margin-411.4%+52.7pp

FCF margin-378.7%+24.1pp

Returns & leverage

See full

Return on equity-61.4%-2.5pp

Debt / equity0.1×+0.1×

Current ratio6×-0.3×

Where this comes from

Reported directly by Nurix Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nurix Therapeutics, Inc.'s AOCI?: Nurix Therapeutics, Inc. (NRIX) reported AOCI of $56K in Q4 2025.
How has Nurix Therapeutics, Inc.'s AOCI changed year-over-year?: Nurix Therapeutics, Inc.'s AOCI decreased by 75.2% year-over-year, from $226K to $56K.
What is the long-term trend for Nurix Therapeutics, Inc.'s AOCI?: Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s AOCI has grown at a 3.8% compound annual growth rate (CAGR), from $87K to $105K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.